Neuroligin 2 inhibitors represent a collection of diverse chemicals that, while not directly binding to neuroligin 2, have the potential to modulate its activity through indirect mechanisms. Tetrodotoxin, a potent neurotoxin, indirectly influences neuroligin 2 by blocking voltage-gated sodium channels, impacting neuronal signaling and synaptic processes involving neuroligin 2. K252a, a kinase inhibitor, may act as an indirect neuroligin 2 inhibitor by influencing various signaling pathways. Its potential to modulate intracellular cascades could impact synaptic function and the activity of neuroligin 2. Ro 25-6981, a selective NMDA receptor antagonist, indirectly affects neuroligin 2 by targeting the NMDA receptor, potentially influencing downstream synaptic processes. The Src family kinase inhibitor PP2, while not directly interacting with neuroligin 2, may act as an indirect inhibitor by affecting signaling pathways involving Src family kinases, influencing neuroligin 2-associated synaptic processes. Wortmannin and LY294002, inhibitors of phosphoinositide 3-kinase (PI3K), indirectly modulate neuroligin 2 through their impact on the PI3K pathway, which plays a role in synaptic function.
U0126, a MEK1/2 inhibitor, serves as a potential indirect neuroligin 2 inhibitor by influencing the MAPK/ERK signaling pathway, implicated in synaptic plasticity. Similarly, Rapamycin, an mTOR inhibitor, may indirectly modulate neuroligin 2 by impacting the mTOR signaling pathway, influencing synaptic plasticity and related functions. SU6656, a selective Src family kinase inhibitor, acts as a potential indirect neuroligin 2 inhibitor by influencing signaling pathways involving Src family kinases. Finally, 2-Aminoethoxydiphenyl borate (2-APB), an inositol trisphosphate receptor (IP3R) inhibitor, indirectly impacts neuroligin 2 by affecting calcium signaling and downstream events involved in neuroligin 2-associated synaptic processes. In summary, these neuroligin 2 inhibitors offer a range of compounds that, through their diverse mechanisms of action, have the potential to modulate the intricate processes associated with neuroligin 2 at the synapse, providing valuable tools for understanding synaptic function and plasticity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $126.00 $210.00 $488.00 | 19 | |
K252a is a kinase inhibitor that can affect various signaling pathways. As a potential indirect inhibitor of neuroligin 2, it may influence intracellular signaling cascades involved in the regulation of synaptic function, impacting the activity of neuroligin 2. | ||||||
Ro 25-6981 maleate | 1312991-76-6 | sc-204887 sc-204887A sc-204887B | 1 mg 10 mg 50 mg | $107.00 $227.00 $930.00 | ||
Ro 25-6981 is a selective antagonist of the NMDA receptor. While not directly targeting neuroligin 2, its impact on NMDA receptor function may have downstream effects on synaptic processes involving neuroligin 2. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is a Src family kinase inhibitor. As a potential indirect inhibitor of neuroligin 2, it may influence signaling pathways involving Src family kinases, affecting synaptic processes where neuroligin 2 is involved. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor. While not a direct inhibitor of neuroligin 2, its impact on the PI3K pathway may modulate downstream signaling events affecting synaptic function and neuroligin 2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. While not a direct inhibitor of neuroligin 2, its impact on the PI3K pathway may modulate downstream signaling events affecting synaptic function and neuroligin 2 activity. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $204.00 | 2 | |
CNQX is an AMPA/kainate receptor antagonist. Although it does not directly target neuroligin 2, its impact on glutamatergic neurotransmission may influence synaptic processes involving neuroligin 2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor. As a potential indirect inhibitor of neuroligin 2, it may modulate the mTOR signaling pathway, impacting synaptic plasticity and neuroligin 2-associated functions. | ||||||
SU6656 | 330161-87-0 | sc-203286 sc-203286A | 1 mg 5 mg | $56.00 $130.00 | 27 | |
SU6656 is a selective Src family kinase inhibitor. As a potential indirect inhibitor of neuroligin 2, it may influence signaling pathways involving Src family kinases, affecting synaptic processes where neuroligin 2 is involved. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-Aminoethoxydiphenyl borate (2-APB) is an inositol trisphosphate receptor (IP3R) inhibitor. While not directly targeting neuroligin 2, its inhibition of IP3R may affect calcium signaling and downstream events involved in synaptic processes associated with neuroligin 2. | ||||||